Melatonin use in managing insomnia in children with autism and other neurogenetic disorders - An assessment by the international pediatric sleep association (IPSA) - Université de Paris - Faculté de Santé Accéder directement au contenu
Article Dans Une Revue Sleep Medicine Année : 2024

Melatonin use in managing insomnia in children with autism and other neurogenetic disorders - An assessment by the international pediatric sleep association (IPSA)

Résumé

Though it is widely prescribed for improving sleep of children with autism and other neurogenetic disorders, there is a need for practical guidance to clinicians on the use of melatonin for managing insomnia in this population. Because data were either lacking or inconclusive, a task force was established by the International Pediatric Sleep Association (IPSA) to examine the literature based on clinical trials from 2012 onwards. A summary of evidence pertaining to melatonin's utility and potential side effects, practice-related caveats, and insights for use are published herewith.
Fichier principal
Vignette du fichier
2024 melatonin.pdf (994.06 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04598769 , version 1 (14-06-2024)

Identifiants

Citer

Suresh Kotagal, Beth Malow, Karen Spruyt, Guanghai Wang, Carlos Ernest Bolaños Almeida, et al.. Melatonin use in managing insomnia in children with autism and other neurogenetic disorders - An assessment by the international pediatric sleep association (IPSA). Sleep Medicine, 2024, 119, pp.222 - 228. ⟨10.1016/j.sleep.2024.04.008⟩. ⟨hal-04598769⟩

Collections

INSERM UP-SANTE
3 Consultations
3 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More